Professor Bradley received his primary medical degree from University College Dublin in 2003.  He completed the Higher Specialist Training Scheme in Neurology with the RCPI and received specialist registration in 2013. His training also included a clinical and research fellowship in Movement Disorders leading to a PhD with Trinity College Dublin in 2012. He was awarded the HSE Richard Steevens scholarship and completed subspecialty fellowships in Stroke and Neuro-Oncology at the National Hospital for Neurology and Neurosurgery, Queen Square, London.

Primary Medical Degree: MB BCh BAO (UCD)
PhD in Neural Engineering (TCD)
Fellow of the Royal College of Physicians of Ireland (RCPI)
Higher Diploma in Statistics (TCD)
Diploma in Stroke and Cerebrovascular Diseases (RCPI)
Faculty Member, Global Brain Health Institute (GBHI)
Fellow of the European Stroke Organisation (ESO)
Member of the Movement Disorders Society (MDS)
Member of the Irish Neurological Association (INA)
Member Irish Consultant Neurologist Association Movement Disorders Group (ICNA)
Irish Hospital Consultants Association New-Entrant Committee (IHCA)
Member of the Irish Heart Foundation (IHF)
Stroke Committee of the Irish Heart Foundation (IHF)

Professor Bradley is a Clinical Associate Professor at the School of Medicine, Trinity College Dublin. He acts as the undergraduate teaching lead for Neurology at St James’s Hospital. He is engaged in teaching and examination of undergraduate medical students, and also provides postgraduate teaching. He is the joint National Specialty Director for Neurology Specialist Training in Ireland and sits on the specialty training committee for Rehabilitation Medicine Specialist Training with the RCPI. He is a faculty member of the Global Brain Health Institute (GBHI).

Professor Bradley is engaged in several national and international studies – his main areas of interest are acute stroke management, stroke risk factors, movement disorders, cognitive disorders. His early work focused on adult-onset dystonia. Professor Bradley is the PI for the St James’s site for the ELAN (Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN) trial (Switzerland). He is the site clinical lead for the AVERT DOSE trial (Australia), a collaborator the CONVINCE trial, the site lead for the HRB Stroke Clinical Trials Network Ireland, a member of the European DLB Consortium (Dementia with Lewy Bodies) and a member of the Dementia Trials Advisory Group for the recently funded HRB Dementia Clinical Trials Network.